{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-071354","form_type":"8-K","ticker":"CRNX","cik":"0001658247","company_name":"Crinetics Pharmaceuticals, Inc.","filed_at":"2024-06-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.464836+00:00","generated_at":"2026-06-01T05:18:52.197620+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Crinetics shareholders re-elect directors, ratify auditor, approve NEO pay","bullets":["Dr. Camille Bedrosian elected with 50.8M votes for (77%), 14.9M withheld; Dr. Wendell Wierenga with 50.3M for (76%).","Ratified BDO USA as independent auditor for FY 2024: 68.0M for, 0.1M against, 16.0K abstain.","Advisory vote on named executive officer compensation approved: 64.1M for, 1.7M against, 6.0K abstain, 2.3M broker non-votes.","Approximately 78.7M shares (86% of eligible) voted at the June 7, 2024 annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-071354","json":"https://secwatch.observer/filing/0000950170-24-071354.json","markdown":"https://secwatch.observer/filing/0000950170-24-071354.md","text":"https://secwatch.observer/filing/0000950170-24-071354.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1658247/000095017024071354/0000950170-24-071354-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1658247/000095017024071354/crnx-20240607.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:18:52.197620+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}